Cargando…
New treatments for multidrug-resistant non-fermenting Gram-negative bacilli Infections
Ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol belong to a novel generation of antibiotics that correspond with the β-lactam family. It is necessary to having new options in treating infections caused by Gram-negative, non-fermenting multidrug-resistant bacilli due to the significant...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedad Española de Quimioterapia
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717454/ https://www.ncbi.nlm.nih.gov/pubmed/36285859 http://dx.doi.org/10.37201/req/s03.12.2022 |
| _version_ | 1784842905149505536 |
|---|---|
| author | Chumbita, Mariana Monzo-Gallo, Patricia Lopera-Mármol, Carlos Aiello, Tommaso Francesco Puerta-Alcalde, Pedro Garcia-Vidal, Carolina |
| author_facet | Chumbita, Mariana Monzo-Gallo, Patricia Lopera-Mármol, Carlos Aiello, Tommaso Francesco Puerta-Alcalde, Pedro Garcia-Vidal, Carolina |
| author_sort | Chumbita, Mariana |
| collection | PubMed |
| description | Ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol belong to a novel generation of antibiotics that correspond with the β-lactam family. It is necessary to having new options in treating infections caused by Gram-negative, non-fermenting multidrug-resistant bacilli due to the significant increase in multidrug resistance in the last decades. Knowing the main characteristics of each drug is key for correct use. |
| format | Online Article Text |
| id | pubmed-9717454 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Sociedad Española de Quimioterapia |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97174542022-12-08 New treatments for multidrug-resistant non-fermenting Gram-negative bacilli Infections Chumbita, Mariana Monzo-Gallo, Patricia Lopera-Mármol, Carlos Aiello, Tommaso Francesco Puerta-Alcalde, Pedro Garcia-Vidal, Carolina Rev Esp Quimioter Update on antimicrobial pharmacotherapy against multidrug-resistant Gram-negative bacilli Ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol belong to a novel generation of antibiotics that correspond with the β-lactam family. It is necessary to having new options in treating infections caused by Gram-negative, non-fermenting multidrug-resistant bacilli due to the significant increase in multidrug resistance in the last decades. Knowing the main characteristics of each drug is key for correct use. Sociedad Española de Quimioterapia 2022-10-24 2022 /pmc/articles/PMC9717454/ /pubmed/36285859 http://dx.doi.org/10.37201/req/s03.12.2022 Text en © The Author 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/). |
| spellingShingle | Update on antimicrobial pharmacotherapy against multidrug-resistant Gram-negative bacilli Chumbita, Mariana Monzo-Gallo, Patricia Lopera-Mármol, Carlos Aiello, Tommaso Francesco Puerta-Alcalde, Pedro Garcia-Vidal, Carolina New treatments for multidrug-resistant non-fermenting Gram-negative bacilli Infections |
| title | New treatments for multidrug-resistant non-fermenting Gram-negative bacilli Infections |
| title_full | New treatments for multidrug-resistant non-fermenting Gram-negative bacilli Infections |
| title_fullStr | New treatments for multidrug-resistant non-fermenting Gram-negative bacilli Infections |
| title_full_unstemmed | New treatments for multidrug-resistant non-fermenting Gram-negative bacilli Infections |
| title_short | New treatments for multidrug-resistant non-fermenting Gram-negative bacilli Infections |
| title_sort | new treatments for multidrug-resistant non-fermenting gram-negative bacilli infections |
| topic | Update on antimicrobial pharmacotherapy against multidrug-resistant Gram-negative bacilli |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717454/ https://www.ncbi.nlm.nih.gov/pubmed/36285859 http://dx.doi.org/10.37201/req/s03.12.2022 |
| work_keys_str_mv | AT chumbitamariana newtreatmentsformultidrugresistantnonfermentinggramnegativebacilliinfections AT monzogallopatricia newtreatmentsformultidrugresistantnonfermentinggramnegativebacilliinfections AT loperamarmolcarlos newtreatmentsformultidrugresistantnonfermentinggramnegativebacilliinfections AT aiellotommasofrancesco newtreatmentsformultidrugresistantnonfermentinggramnegativebacilliinfections AT puertaalcaldepedro newtreatmentsformultidrugresistantnonfermentinggramnegativebacilliinfections AT garciavidalcarolina newtreatmentsformultidrugresistantnonfermentinggramnegativebacilliinfections |